GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
135.38
-2.09 (-1.52%)
At close: Jan 9, 2026, 4:00 PM EST
135.38
0.00 (0.00%)
After-hours: Jan 9, 2026, 4:10 PM EST
GeneDx Holdings Revenue
GeneDx Holdings had revenue of $116.74M in the quarter ending September 30, 2025, with 51.86% growth. This brings the company's revenue in the last twelve months to $402.19M, up 50.50% year-over-year. In the year 2024, GeneDx Holdings had annual revenue of $305.45M with 50.79% growth.
Revenue (ttm)
$402.19M
Revenue Growth
+50.50%
P/S Ratio
9.68
Revenue / Employee
$402,190
Employees
1,000
Market Cap
3.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 305.45M | 102.88M | 50.79% |
| Dec 31, 2023 | 202.57M | -32.13M | -13.69% |
| Dec 31, 2022 | 234.69M | 22.50M | 10.60% |
| Dec 31, 2021 | 212.20M | 32.87M | 18.33% |
| Dec 31, 2020 | 179.32M | -16.85M | -8.59% |
| Dec 31, 2019 | 196.17M | 62.83M | 47.12% |
| Dec 31, 2018 | 133.34M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
WGS News
- 1 day ago - GeneDx and Komodo Health Partner to Build the World's Most Complete Longitudinal Rare Disease Dataset - Business Wire
- 2 days ago - GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care - Business Wire
- 3 days ago - GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care - Business Wire
- 4 days ago - GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025 - Business Wire
- 10 days ago - GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference - Business Wire
- 25 days ago - JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year - Business Wire
- 4 weeks ago - Eight stock picks to play one of the healthiest corners of the market - Market Watch
- 5 weeks ago - HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire